Treatment of infertility in women with pituitary tumors

Jennifer Hirshfeld-Cytron, Helen Kim*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Due to the pituitary's critical position, a pituitary tumor may disrupt gonadal function, either by its expanding size or the inappropriate secretion of hormones. Menstrual cycles may be disrupted even without frank hypogonadism, particularly in the case of hormone-secreting adenomas. Despite optimal medical and surgical management of pituitary tumors, ovulation-induction therapy with gonadotropins is often required to restore fertility in these women. This article will provide an overview of the therapeutic options available for women with infertility resulting from pituitary tumors. Treatment strategies including dopamine agonists, gonadotropins and the role of assisted reproductive technologies will be discussed. Unique pregnancy considerations in the female patient with hypopituitarism will also be addressed.

Original languageEnglish (US)
Pages (from-to)S55-S62
JournalExpert review of anticancer therapy
Issue number9 SUPPL.
StatePublished - Sep 2006


  • Assisted reproduction
  • Dopamine agonists
  • Follicle-stimulating hormone
  • Gonadotropins
  • Human chorionic gonadotropin
  • Hyperprolactinemia
  • In vitro fertilization
  • Infertility
  • Luteinzing hormone
  • Pituitary adenoma

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology


Dive into the research topics of 'Treatment of infertility in women with pituitary tumors'. Together they form a unique fingerprint.

Cite this